P
Paulus Kirchhof
Researcher at University of Birmingham
Publications - 659
Citations - 119822
Paulus Kirchhof is an academic researcher from University of Birmingham. The author has contributed to research in topics: Atrial fibrillation & Medicine. The author has an hindex of 100, co-authored 558 publications receiving 106459 citations. Previous affiliations of Paulus Kirchhof include United States Department of Veterans Affairs & Georgetown University Medical Center.
Papers
More filters
Journal ArticleDOI
Indications for the use of diagnostic implantable and external ECG loop recorders
Michele Brignole,Panos E. Vardas,Ellen Hoffman,Heikki V. Huikuri,Angel Moya,Renato Pietro Ricci,Neil Sulke,Wouter Wieling,Angelo Auricchio,Gregory Y.H. Lip,Jesús Almendral,Paulus Kirchhof,Etienne Aliot,Maurizio Gasparini,Frieder Braunschweig,Gian Luca Botto +15 more
TL;DR: This early loop recorder approach implies the need for careful initial risk stratification in order to exclude from such a strategy patients with potential life-threatening conditions that require immediate hospitalization or intensive evaluation and treatment.
Journal ArticleDOI
A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry
Gregory Y.H. Lip,Cécile Laroche,Gheorghe-Andrei Dan,Massimo Santini,Zbigniew Kalarus,Lars Hvilsted Rasmussen,Mário Oliveira,Georges H. Mairesse,Harry J.G.M. Crijns,Emmanouil Simantirakis,Dan Atar,Paulus Kirchhof,Paulus Kirchhof,Panos E. Vardas,Luigi Tavazzi,Aldo P. Maggioni +15 more
TL;DR: The EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot Registry has provided systematic collection of contemporary data regarding the management and treatment of AF by cardiologists in ESC member countries.
Journal ArticleDOI
PITX2c is Expressed in the Adult Left Atrium, and Reducing Pitx2c Expression Promotes Atrial Fibrillation Inducibility and Complex Changes in Gene Expression
Paulus Kirchhof,Peter C. Kahr,Sven Kaese,Ilaria Piccini,Ismail Vokshi,H. H. Scheld,Heinrich Rotering,Lisa Fortmueller,Sandra Laakmann,Sander Verheule,Ulrich Schotten,Larissa Fabritz,Nigel A. Brown +12 more
TL;DR: A physiological role for PITx2 in the adult heart is demonstrated and the hypothesis that dysregulation of PITX2 expression can be responsible for susceptibility to atrial fibrillation is supported.
Journal ArticleDOI
Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association.
Paulus Kirchhof,Angelo Auricchio,Jeroen J. Bax,Harry J.G.M. Crijns,John Camm,Hans-Christoph Diener,Andreas Goette,Gerd Hindricks,Stefan H. Hohnloser,Lukas Kappenberger,Karl Heinz Kuck,Gregory Y.H. Lip,Bertil Olsson,Thomas Meinertz,Silvia G. Priori,Ursula Ravens,Gerhard Steinbeck,Elisabeth Svernhage,Jan G.P. Tijssen,Alphons Vincent,Günter Breithardt +20 more
TL;DR: An expert consensus is described of required outcome parameters in seven relevant outcome domains, namely death, stroke, symptoms and quality of life, rhythm, left ventricular function, cost, and emerging outcome parameters for outcome assessment in AF trials.
Journal ArticleDOI
The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials
Stefan D. Anker,Stefan D. Anker,Stefan Agewall,Martin Borggrefe,Melanie Calvert,J. Jaime Caro,Martin R. Cowie,Ian Ford,Jean A. Paty,Jillian P. Riley,Karl Swedberg,Karl Swedberg,Luigi Tavazzi,Ingela Wiklund,Paulus Kirchhof +14 more
TL;DR: Cardiovascular clinical research should shift its focus to include PROs when evaluating the efficacy of therapeutic interventions, and PRO assessments should be scientifically rigorous.